Financials data is unavailable for this security.
View more
Year on year USANA Health Sciences Inc 's revenues fell -7.77% from 998.60m to 921.01m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 69.35m to 63.79m, a -8.02% decrease.
Gross margin | 80.77% |
---|---|
Net profit margin | 6.29% |
Operating margin | 9.64% |
Return on assets | 8.93% |
---|---|
Return on equity | 11.23% |
Return on investment | 10.84% |
More ▼
Cash flow in USDView more
In 2023, USANA Health Sciences Inc increased its cash reserves by 14.39%, or 41.93m. The company earned 70.64m from its operations for a Cash Flow Margin of 7.67%. In addition the company used 11.98m on investing activities and also paid 14.24m in financing cash flows.
Cash flow per share | 3.54 |
---|---|
Price/Cash flow per share | 11.21 |
Book value per share | 26.89 |
---|---|
Tangible book value per share | 24.50 |
More ▼
Balance sheet in USDView more
Current ratio | 4.03 |
---|---|
Quick ratio | 3.44 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -8.43 |
---|---|
EPS (TTM) vs TTM 1 year ago | -12.89 |